Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SciSparc

Recent news which mentions SciSparc

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
Tickers CMND NEWS SPRC
Tags Press Releases SPRC SciSparc
From Benzinga
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIDU DE EVS MARA
Tags Benzinga Market News Baidu
From Benzinga
SciSparc Signs LOI to Sell 50% Interest in Subsidiary
Tickers JFBR SPRC
Tags SPRC SciSparc Penny Stocks
From Benzinga
Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
Tickers AMPH
Tags Market News AMPH Biotech
From Benzinga
SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs
Tickers SPRC
Tags Benzinga News Market News
From Benzinga
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
Tickers SPRC
Tags SPRC Press Releases SciSparc
From Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
Tickers CMNDF SPRC
Tags Partner Content General SPRC
From Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
Tickers CMNDF SPRC
Tags General SciSparc SPRC
From Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
Tickers CMNDF SPRC
Tags Clearmind Medicine psychedelic compound MEAI CMNDF
From Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
Tickers SPRC
Tags Press Releases SPRC SciSparc
From Benzinga
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
Tickers BIIB LLY PFE SAVA
Tags Market News Benzinga Biotech
From Benzinga
SciSparc Announces Buyback Equal To 12% Of Float
Tickers SPRC
Tags Benzinga News Market News
From Benzinga
SciSparc Completes Development Of Its Proprietary Drug Candidate SCI-110 To Treat Tourette Syndrome
Tickers SPRC
Tags News Biotech Benzinga
From Benzinga
SciSparc Successfully Completed The Development Of Its Proprietary Drug Candidate SCI-110 For Its Upcoming Phase IIb Study In Tourette Syndrome
Tickers SPRC
Tags Partner Content SPRC Penny Stocks
From Benzinga
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
Tickers ABC CAH JNJ MCK
Tags Health Care Distributors Health Care Benzinga
From Benzinga
SciSparc Receives Ethics Committee Approval To Conduct Clinical Trial In ASD With Proprietary SCI-210 Treatment
Tickers SPRC
Tags Market News Benzinga Biotech
From Benzinga
SciSparc Announces Ethics Committee Approval To Conduct Its Clinical Trial In Autism Spectrum Disorder
Tickers SPRC
Tags Partner Content SPRC Penny Stocks
From Benzinga
SciSparc Reinforces Its New JV For Targeting Discovery With A Global Expert In The Field Of Mitochondrial Transport Proteins
Tickers SPRC
Tags General SciSparc SPRC
From Benzinga
Initial Positive Results For Cocaine Addiction Treatment Announced
Tickers SPRC
Tags News Biotech Benzinga
From Benzinga
SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.
Tickers CMNDF SPRC
Tags Partner Content General SPRC
From Benzinga
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
Tickers CMNDF SPRC
Tags Market News CMNDF Biotech
From Benzinga
SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems
Tickers SPRC
Tags Partner Content Penny Stocks SPRC
From Benzinga
SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome
Tickers SPRC
Tags News Biotech Benzinga
From Benzinga
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome
Tickers SPRC
Tags Market News Biotech Benzinga
From Benzinga
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
Tickers JNJ RDY SPRC
Tags JNJ Market News Cryptocurrency
From Benzinga
SciSparc And Clearmind Medicine Inc. Collaboration Yields Positive Results For Its Psychedelic Combination Treatment
Tickers SPRC
Tags Psychedelics Benzinga Market News
From Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
Tickers ABC JNJ SPRC
Tags SPRC SciSparc Penny Stocks
From Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
Tickers ABC JNJ SPRC
Tags Markets Partner Content SPRC
From Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
Tickers SPRC
Tags Partner Content General SPRC
From Benzinga
Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested
Tickers CMNDF SPRC
Tags Cannabis Psychedelics Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.